Beginning September 1, 2018, Paragard will have a new National Drug Code (NDC) under CooperSurgical. The new NDC will be 59365-5128-1.

Please take a moment IMMEDIATELY to update any of your reimbursement, billing and ordering systems to reflect this change. For existing Teva stock, see note below.


NDC Codes636713276772091607


Paragard csi

IF YOU RETAIN TEVA INVENTORY:Paragard labeled with the Teva Pharmaceuticals NDC, will still be able to be used without any issue.However, you will need to continue to bill and run that inventory through the system using the old, Teva NDC number 5128-204-01 until it runs out.


Old Paragard

CooperSurgical is notifying all customers and business associates to this change and we would appreciate your partnership in helping us ensure that all systems and locations involved with Paragard are updated with the new NDC number.

Once you begin receiving Paragard with CooperSurgical labeling, you should begin billing with the NEW CooperSurgical NDC.For any questions, contact CooperSurgical at 1.877.PARAGARD.


PARAGARD is indicated for intrauterine contraception for up to 10 years.


  • Paragard must not be used by women who have acute pelvic inflammatory disease (PID); have had a postpregnancy or postabortion uterine infection in the past 3 months; have cancer of the uterus or cervix; have an infection of the cervix; have an allergy to any component; or have Wilson's disease.
  • If a woman misses her period, she must be promptly evaluated for pregnancy.
  • Possible serious complications that have been associated with intrauterine contraceptives are PID, embedment, perforation of the uterus, and expulsion.
  • Paragard must not be used by women who are pregnant as this can be life threatening and may result in loss of pregnancy or infertility.
  • The most common side effects of Paragard are bleeding and spotting; for most women, these typically subside after 2 to 3 months.
  • Paragard does not protect against HIV or other sexually transmitted infections (STI).

For full product information, please see the Full Prescribing Information.


1Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use; 2017.

2Kaneshiro B, Aeby T. Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device. Int J Womens Health. 2010;2:211-220.

*According to the Centers for Disease Control and Prevention (CDC), Paragard is one of the least restrictive birth control options across all patient types compared to other IUDs.